Health-related quality of life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: a systematic review

V Landry, E Siciliani, M Henry, RJ Payne - Current Oncology, 2022 - mdpi.com
Health-related quality of life (HrQoL) is a major concern for patients with differentiated
thyroid carcinoma (DTC). We aimed to systematically review the literature comparing HrQol …

Thyroid lobectomy for low to intermediate risk differentiated thyroid cancer

DM Hartl, J Guerlain, I Breuskin, J Hadoux, E Baudin… - Cancers, 2020 - mdpi.com
Simple Summary Total thyroidectomy used to be recommended for all thyroid cancers. We
now know that some thyroid cancers have a relatively low risk of recurrence. Today, for …

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial

EJ de Koster, D Vriens, MO van Aken… - European journal of …, 2022 - Springer
Purpose To evaluate cost-effectiveness of an [18F] FDG-PET/CT-driven diagnostic workup
as compared to diagnostic surgery, for thyroid nodules with Bethesda III/IV cytology.[18F] …

MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer

MJH Metman, PKC Jonker, LHJ Sondorp… - European Journal of …, 2024 - Springer
Purpose Multifocal disease in PTC is associated with an increased recurrence rate.
Multifocal disease (MD) is underdiagnosed with the current gold standard of pre-operative …

Long-term health-related quality of life outcomes following thyroid surgery for malignant or benign disease: deficits persist in cancer survivors beyond five years

NDA Blefari, CW Rowe, E Wiadji, D Lambkin… - World Journal of …, 2022 - Springer
Background Thyroid cancer diagnoses are increasing and treatment can lead to significant
morbidity. Long-term health-related quality of life (HRQoL) in thyroid cancer is understudied …

Long-term outcome of lobectomy for thyroid cancer

M Bosset, M Bonjour, S Castellnou… - European Thyroid …, 2021 - etj.bioscientifica.com
Introduction: Recent guidelines of the American Thyroid Association (ATA) suggest that a
lobectomy may be sufficient to treat low-to intermediate-risk patients with thyroid tumors≤ 40 …

[HTML][HTML] Continuing controversy regarding individualized surgical decision-making for patients with 1–4 cm low-risk differentiated thyroid carcinoma: a systematic …

W Liu, X Yan, R Cheng - European Journal of Surgical Oncology, 2020 - Elsevier
Implementing high-quality randomized controlled trials is difficult for patients with 1–4 cm
low-risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether …

Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer

PM Rodriguez Schaap, JF Lin… - JNCI: Journal of the …, 2023 - academic.oup.com
Background The impact of multifocality and bilaterality on recurrence in patients with low-risk
papillary thyroid cancer (PTC) is relevant when considering patients for a de-escalated …

Predictive factors indicative of hemithyroidectomy and close follow-up versus bilateral total thyroidectomy for aggressive variants of papillary thyroid cancer

IA Lee, G Moon, S Kang, KH Lee, SM Lee, JK Kim… - Cancers, 2022 - mdpi.com
Simple Summary This study evaluated the need for additional surgical treatment in patients
diagnosed with aggressive variants of papillary thyroid cancer after lobectomy. With the …

Current therapeutic options for low‐risk papillary thyroid carcinoma: Scoping evidence review

A Sanabria, P Pinillos, RB Lira, JP Shah… - Head & …, 2022 - Wiley Online Library
Most cases of thyroid carcinoma are classified as low risk. These lesions have been treated
with open surgery, remote access thyroidectomy, active surveillance, and percutaneous …